Recruiting Melanoma Studies in Lancaster
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell...
Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma
The main purpose of this study is to determine the safety of combining ipilimumab and nivolumab with hypofractionated radiotherapy to a single tumor in patients with metastatic melanoma. Another purpo...
About Melanoma Clinical Trials in Lancaster
Melanoma is the most serious type of skin cancer, developing from the pigment-producing cells known as melanocytes. While less common than other skin cancers, melanoma is more likely to spread. Immunotherapy and targeted therapy have revolutionized melanoma treatment.
There are currently 2 melanoma clinical trials recruiting participants in Lancaster, PENNSYLVANIA. These studies are seeking a combined 474 participants. Research is being sponsored by National Cancer Institute (NCI), Abramson Cancer Center at Penn Medicine. Clinical trial participation is free and participants receive study-related medical care at no cost.
Melanoma Clinical Trials in Lancaster — FAQ
Are there melanoma clinical trials in Lancaster?
Yes, there are 2 melanoma clinical trials currently recruiting in Lancaster, PENNSYLVANIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Lancaster?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lancaster research site will contact you about next steps.
Are clinical trials in Lancaster free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lancaster studies also compensate for your time and travel.
What melanoma treatments are being tested?
The 2 active trials in Lancaster are testing new therapies including novel drugs, biologics, and treatment approaches for melanoma.
Data updated March 2, 2026 from ClinicalTrials.gov